These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1603565)

  • 41. [Clinical, epidemiological and evolutionary aspects in 157 cases of cutaneous leishmaniasis in Morocco].
    Hjira N; Frikh R; Marcil T; Lamsyah H; Oumakhir S; Baba N; Boui M
    Pan Afr Med J; 2014; 17():272. PubMed ID: 25309671
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Leishmaniasis of the Feet Sole: A Case Report.
    Ayatollahi J; Bafghi AF; Shahcheraghi SH
    Turkiye Parazitol Derg; 2017 Mar; 41(1):48-49. PubMed ID: 28483734
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unusual association of American cutaneous leishmaniasis and acquired immunodeficiency syndrome.
    Nogueira-Castañon MC; Pereira CA; Furtado T
    Int J Dermatol; 1996 Apr; 35(4):295-7. PubMed ID: 8786193
    [No Abstract]   [Full Text] [Related]  

  • 45. Chronic zosteriform cutaneous leishmaniasis.
    Omidian M; Mapar MA
    Indian J Dermatol Venereol Leprol; 2006; 72(1):41-2. PubMed ID: 16481709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of antimonial therapy for canine leishmaniasis on antibody titer.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():444-6. PubMed ID: 9668509
    [No Abstract]   [Full Text] [Related]  

  • 47. Rare variants of Cutaneous Leishmaniasis: whitlow, paronychia, and sporotrichoid.
    Iftikhar N; Bari I; Ejaz A
    Int J Dermatol; 2003 Oct; 42(10):807-9. PubMed ID: 14521695
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.
    Arevalo I; Ward B; Miller R; Meng TC; Najar E; Alvarez E; Matlashewski G; Llanos-Cuentas A
    Clin Infect Dis; 2001 Dec; 33(11):1847-51. PubMed ID: 11692295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. American cutaneous leishmaniasis as a rare imported disease in Europe: a case report favourably treated with antimonial derivatives.
    Manfredi R; di Bari MA; Calza L; Chiodo F
    Eur J Epidemiol; 2001; 17(8):793-5. PubMed ID: 12086100
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative histological and immunohistochemical changes of dry type cutaneous leishmaniasis after administration of meglumine antimoniate, imiquimod or combination therapy.
    Shamsi Meymandi S; Javadi A; Dabiri S; Shamsi Meymandi M; Nadji M
    Arch Iran Med; 2011 Jul; 14(4):238-43. PubMed ID: 21726098
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
    Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
    Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute pancreatitis associated with the administration of meglumine antimonate for the treatment of visceral leishmaniasis.
    de Lalla F; Pellizzer G; Gradoni L; Vespignani M; Franzetti M; Stecca C
    Clin Infect Dis; 1993 May; 16(5):730-1. PubMed ID: 8507769
    [No Abstract]   [Full Text] [Related]  

  • 53. Efficacy of local heat therapy by radiofrequency in the treatment of cutaneous leishmaniasis, compared with intralesional injection of meglumine antimoniate.
    Sadeghian G; Nilfroushzadeh MA; Iraji F
    Clin Exp Dermatol; 2007 Jul; 32(4):371-4. PubMed ID: 17376205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disseminated cutaneous leishmaniasis caused by Leishmania braziliensis in Southern Brazil.
    Membrive NA; Kazuma FJ; Silveira TGV; Teixeira JJV; Reinhold-Castro KR; Teodoro U
    Rev Inst Med Trop Sao Paulo; 2017 Jun; 59():e37. PubMed ID: 28591265
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meglumine antimoniate is more effective than sodium stibogluconate in the treatment of cutaneous leishmaniasis.
    Yesilova Y; Surucu HA; Ardic N; Aksoy M; Yesilova A; Oghumu S; Satoskar AR
    J Dermatolog Treat; 2016; 27(1):83-7. PubMed ID: 26105204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
    Salmanpour R; Razmavar MR; Abtahi N
    Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of cutaneous leishmaniasis with antimony: intramuscular versus intralesional administration.
    Alkhawajah AM; Larbi E; al-Gindan Y; Abahussein A; Jain S
    Ann Trop Med Parasitol; 1997 Dec; 91(8):899-905. PubMed ID: 9579209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS).
    Hernández DE; Oliver M; Martínez C; Planas G
    Int J Dermatol; 1995 Feb; 34(2):114-5. PubMed ID: 7737768
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
    Romero GA; Guerra MV; Paes MG; Macêdo VO
    Am J Trop Med Hyg; 2001 Nov; 65(5):456-65. PubMed ID: 11716098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.